Pharmacology and mechanisms of apigenin in preventing osteoporosis DOI Creative Commons
Lin Sun,

Wang Yincang,

Du Jiazhe

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Дек. 12, 2024

Osteoporosis (OP) stands as the most prevalent systemic skeletal condition associated with aging. The current clinical management of OP predominantly depends on anti-resorptive and anabolic agents. Nevertheless, prolonged use some these medications has been observed to reduce efficacy elevate adverse effects. Given necessity for sustained or even lifelong treatment OP, identification drugs that are not only effective but also safe cost-efficient is utmost significance. As disease paradigms continue evolve recent advancements in research come light, certain plant-derived compounds have emerged, presenting notable benefits OP. This review primarily explores pharmacological properties apigenin elucidates its therapeutic mechanisms context insights provided herein aspire offer a foundation judicious forthcoming research, particularly within scope

Язык: Английский

Utilization of natural products in diverse pathogeneses of diseases associated with single or double DNA strand damage repair DOI Creative Commons

Jiali Liang,

Wanqing Liu, Tong Zhang

и другие.

Chinese Medicine, Год журнала: 2025, Номер 20(1)

Опубликована: Апрель 7, 2025

Abstract The appearance of DNA damage often involves the participation related enzymes, which can affect onset and development various diseases. Several natural active compounds have been found to efficiently adjust activity crucial enzymes associated with single or double-strand damage, thus demonstrating their promise in treating This paper provides an in-depth examination summary these modulation mechanisms, leading a thorough review subject. connection between disease is explored through analysis structural characteristics compounds. By reviewing how different scholarly sources describe identical structures using varied terminology, this study also delves into effects on enzyme regulation. offers potentially be used therapeutically influence key activities expression levels, turn process repair (DDR). These shown not only reduce occurrence but boost efficiency processes, presenting new therapeutic opportunities for conditions such as cancer other pathologies. Future research should focus clarifying exact mechanisms maximize clinical utility support creation novel approaches prevention treatment. Graphical abstract

Язык: Английский

Процитировано

0

Pharmacology and mechanisms of apigenin in preventing osteoporosis DOI Creative Commons
Lin Sun,

Wang Yincang,

Du Jiazhe

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Дек. 12, 2024

Osteoporosis (OP) stands as the most prevalent systemic skeletal condition associated with aging. The current clinical management of OP predominantly depends on anti-resorptive and anabolic agents. Nevertheless, prolonged use some these medications has been observed to reduce efficacy elevate adverse effects. Given necessity for sustained or even lifelong treatment OP, identification drugs that are not only effective but also safe cost-efficient is utmost significance. As disease paradigms continue evolve recent advancements in research come light, certain plant-derived compounds have emerged, presenting notable benefits OP. This review primarily explores pharmacological properties apigenin elucidates its therapeutic mechanisms context insights provided herein aspire offer a foundation judicious forthcoming research, particularly within scope

Язык: Английский

Процитировано

1